Marketing-claims review program

Description

Deceptive-practices prohibitions are the consumer-protection backstop that runs underneath every other product-level rule. FTC Act §5 in the US, the EU Unfair Commercial Practices Directive (UCPD) Articles 5 through 9 plus the Annex I "always unfair" list, the UK CPRs 2008 (now updated by the DMCC Act 2024), Brazil's Consumer Defense Code, the Australian Consumer Law, and equivalents in most major markets all share the same doctrinal shape: a representation is deceptive if it is likely to mislead a reasonable consumer about a material fact, and unfair if it causes substantial consumer injury that is not reasonably avoidable. The doctrine is intentionally broad so it can reach novel manipulative practices that the legislature did not anticipate, and the operational consequence is that the prohibition program has to be claim-level proactive rather than complaint-driven reactive. A working program has three operational components. The screening workflow runs marketing claims, product descriptions, comparative advertising, and pricing representations through legal review before publication. The threshold for review gets tuned to risk: high-risk claim categories (efficacy claims, savings claims, environmental claims, comparative claims naming a competitor, "Made in USA" or origin claims, free-trial and subscription disclosures) route through legal review every time; lower-risk claims go through a marketing-and-content lead with escalation triggers. The substantiation file holds the proof for every express claim that requires it, and the file structure is what makes the program survive an FTC civil investigative demand or a regulator inquiry: each claim links to the specific evidence (clinical study, customer-survey data, competitive-product testing) that supports it, with the evidence maintained in a form that can be produced under subpoena. The periodic audit of live representations against the substantiation files catches drift over time as marketing teams iterate copy; a claim that was substantiated at launch may have evolved through repeated copy reviews into a stronger version of itself, and the live-claim audit catches the gap before the regulator does. The UCPD Annex I list is the highest-risk corner of the EU regime: those 31 practices are deceptive per se with no reasonable-consumer test, and "we did not realize that was on the list" is not available as a defense. The statutory anchors layer across the principal regimes an operator typically resolves in parallel. US: FTC Act §5 at 15 U.S.C. §45 (the general unfair or deceptive acts or practices prohibition), enforcement via consent decrees, administrative orders, and §13(b) federal-court actions for restitution and disgorgement; 16 CFR Parts 255 (endorsement guides) and 425 (negative-option features); CAN-SPAM at 15 U.S.C. §§7701-7713 layering for email. EU: UCPD (Directive 2005/29/EC) Articles 5 through 8 (general prohibition, misleading actions, misleading omissions, aggressive practices) plus Annex I always-unfair list, with the Omnibus Directive (Directive (EU) 2019/2161) layering newer prohibitions on hidden paid placement, false urgency, and price-history disclosure manipulation. UK: DMCC Act 2024 c. 13 carrying forward the CPRs 2008 framework with enhanced CMA enforcement powers. Brazil CDC (Lei nº 8.078/1990) Articles 36-37 prohibiting misleading and abusive advertising. Australia ACL §18 (misleading or deceptive conduct) plus §29 (false or misleading representations) under the Competition and Consumer Act 2010 Schedule 2. Japan SCT (Act No. 57 of 2000 as amended) plus Premiums and Representations Act layer misleading-pricing prohibitions. India E-Commerce Rules 2020 prohibit artificial scarcity and flash-sale manipulation. Korea Act No. 6687 and Saudi Royal Decree M/126 set the parallel regimes. Evidence formats that satisfy a regulator inquiry include the marketing-claim substantiation file per express claim, the internal review SOP plus sign-off matrix, the audit log of comparative-advertising reviews, training records for marketing and content authors, and the remediation log for flagged claims.

Applicability

Applies when: customer segment is b2c or b2b2c.

How predicates are evaluated

Required by (14 regulations)

• ACL

  ACL §18 misleading or deceptive conduct + §29 false or misleading representations.

  Competition and Consumer Act 2010, Schedule 2

• FTC Act

  FTC Act §5 (15 U.S.C. § 45): prohibition on unfair or deceptive acts or practices in or affecting commerce. Enforcement via consent decrees, administrative orders, and §13(b) federal-court actions for restitution and disgorgement.

  15 U.S.C. §§41-58; 16 CFR Parts 255, 425

  Source →

• CDC

  CDC Articles 36-37: misleading + abusive advertising prohibitions.

  Lei nº 8.078, de 11 de setembro de 1990 (Código de Defesa do Consumidor), regulated by Decreto nº 7.962, de 15 de março de 2013 (e-commerce provisions)

• CAN-SPAM

  15 U.S.C. §§7701-7713; 16 CFR Part 316

• Omnibus

  Directive (EU) 2019/2161

• E-Commerce Rules

  E-commerce Rules prohibition on artificial scarcity / flash-sale manipulation (india-ec-no-flash-sale-manipulation).

  Consumer Protection (E-Commerce) Rules, 2020, issued under the Consumer Protection Act, 2019 (Act No. 35 of 2019), as amended through 2023

• ASCT

  SCT misleading-pricing prohibition (japan-sct-misleading-pricing) + Premiums and Representations Act.

  Act on Specified Commercial Transactions (Act No. 57 of 2000, as amended by Act No. 70 of 2021, effective June 1, 2022)

• Korea E-Commerce Act

  Act on the Consumer Protection in Electronic Commerce, etc. (Act No. 6687)

• E-Commerce Law

  Royal Decree M/126, Electronic Commerce Law, issued 7/11/1440 AH (July 10, 2019), effective 19/2/1441 AH (October 19, 2019)

• UCPD

  Directive 2005/29/EC general prohibition (Article 5), misleading actions (Article 6), misleading omissions (Article 7), aggressive practices (Article 8), Annex I always-unfair list (including 'free' claim restrictions).

  Directive 2005/29/EC of the European Parliament and of the Council

• California SB 1001

  Supports SB 1001 by preventing the intent-to-mislead about artificial identity that the statute prohibits.

  California SB 1001 (2018), B.O.T. Act

  Source →

• EU Empowering Consumers

  Supports the directive's amended UCPD prohibitions on misleading environmental claims (Directive (EU) 2024/825).

  Empowering Consumers for the Green Transition Directive

  Source →

• FTC Green Guides

  Supports FTC Act Section 5 deception avoidance for environmental marketing claims, which the Green Guides interpret (16 CFR Part 260).

  FTC Guides for the Use of Environmental Marketing Claims

  Source →

• FTC AI Advertising

  FTC guidance treats unsubstantiated or misleading AI claims as deceptive practices under Section 5 of the FTC Act.

  15 U.S.C. §§41-58 (FTC Act §5); FTC business-guidance documents including 'Keep Your AI Claims in Check' (April 2023), 'Aiming for truth, fairness, and equity in your company's use of AI' (April 2021), Endorsement Guides (16 CFR Part 255, updated 2023)

  Source →

Fulfilled by (1)

• In-house build · medium effort
  Legal-marketing partnership with claim-substantiation database + pre-publication review workflow. Periodic outside-counsel review of marketing materials remains the gold-standard mitigation for UCPD Annex I and comparative claims; engage qualified counsel for the relevant jurisdiction.

Magist does not accept payment from vendors. Methodology.

Evidence formats

• marketing-claim substantiation file per express claim
• internal review SOP + sign-off matrix
• audit log of comparative-advertising reviews
• training records for marketing + content authors
• remediation log for flagged claims